PSG — PharmaSGP Holding SE Cashflow Statement
0.000.00%
Last trade - 00:00- €347.72m
- €384.71m
- €101.10m
- 94
- 40
- 88
- 91
Annual cashflow statement for PharmaSGP Holding SE, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 16.7 | 10.6 | 10.7 | 12 | 16.4 |
| Depreciation | |||||
| Non-Cash Items | -0.432 | 0.157 | 0.907 | 4.08 | 4.43 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.96 | 4.17 | -2.93 | -0.571 | -3.56 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 17.6 | 15.5 | 12.2 | 24.7 | 26.6 |
| Capital Expenditures | -0.433 | -0.898 | -83.5 | -0.787 | -0.866 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.109 | 0 | — | — | — |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.324 | -0.898 | -83.5 | -0.787 | -0.866 |
| Financing Cash Flow Items | -5.58 | -94.8 | -0.643 | -1.8 | -2.99 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -5.84 | -95 | 84 | -12.1 | -17.6 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 11.5 | -80.5 | 12.8 | 11.8 | 8.12 |